Adicet Bio
ACET
Adicet Bio (ACET) news
Recent news
Adicet Bio stock sinks on proposed public offering
Adicet Bio stock sinks on proposed public offering Adicet Bio, a biotechnology company specializing in gamma delta T cell therapies, saw its stock sink after announcing a proposed public offering. The offering, which aimed to raise $75 million through the sale of 4.5 million shares, was ultimately…
AInvest Wire · Jan 22, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
